| Weight | 1 lbs |
|---|---|
| Dimensions | 9 × 5 × 2 in |
| target | Coxsackie Virus reactive IgA |
| species reactivity | Coxsackievirus (hand, foot, and mouth disease) |
| applications | ELISA |
| assay type | Indirect & quantitative |
| available size | 3 mL |
Coxsackie IgA Virus Control Serum BC134A
$94.00
Summary
- Virion/Serion Diagnostic Kit Control for research use (RUO)
- Coxsackie IgA Virus Control Serum
- Applications: ELISA
- IgA control serum
- Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
- 3 mL
Coxsackie IgA Virus Control Serum BC134A
| kit |
|---|
| Research area Infectious Disease |
| Storage Store at 2-8°C. |
| Associated products Coxsackievirus Antigen (BA134VS01) Cocksackie IgA Virus Control Serum (BC134A) Cocksackie IgG Virus Control Serum (BC134G) Cocksackie IgM Virus Control Serum (BC134M) Cocksackievirus IgA ELISA Kit (ESR134A) Cocksackievirus IgG ELISA Kit (ESR134G) Cocksackievirus IgM ELISA Kit (ESR134M) |
| target relevance |
|---|
| Organism Coxsackievirus |
| Protein names Coxsackievirus |
| Structure and strains Coxsackieviruses are a few related enteroviruses that belong to the Picornaviridae family of nonenveloped, linear, positive-sense single-stranded RNA viruses, as well as its genus Enterovirus, which also includes poliovirus and echovirus. Enteroviruses are among the most common and important human pathogens, and ordinarily its members are transmitted by the fecal oral route. Coxsackieviruses share many characteristics with poliovirus. With control of poliovirus infections in much of the world, more attention has been focused on understanding the nonpolio enteroviruses such as coxsackievirus. Coxsackieviruses are among the leading causes of aseptic meningitis (the other usual suspects being echovirus and mumps virus). The entry of coxsackievirus into cells, especially endothelial cells, is mediated by coxsackievirus and adenovirus receptor. |
| Detection and diagnosis The demonstration of infection by the detection of specific antibodies generally requires the analysis of serum pairs. A positive result for IgM or IgA combined with rising IgG activity serves as clear evidence of an acute or recent infection. Persisting IgM and IgA antibody levels are frequently observed in chronic infections. |
Data
FAQ & Publications
Frequently Asked Questions
What is the intended application of the Coxsackie IgA Virus Control Serum BC134A?
The Coxsackie IgA Virus Control Serum BC134A is designed for use as a control serum in ELISA assays, specifically indirect and quantitative ELISA methods.
How should the Coxsackie IgA Virus Control Serum BC134A be stored to ensure stability?
This control serum should be stored refrigerated at 2-8°C to maintain its stability and efficacy.
Is the Coxsackie IgA Virus Control Serum BC134A compatible with SERION ELISA kits?
Yes, the serum is ready-to-use and pre-diluted specifically for SERION ELISA classic and SERION ELISA antigen assays, ensuring compatibility with these kits.
Which viral target and antibody class does the Coxsackie IgA Virus Control Serum BC134A detect?
This control serum targets Coxsackie virus-reactive IgA antibodies, allowing for the detection of IgA responses to Coxsackievirus infections.
Publications
| pmid | title | authors | citation |
|---|---|---|---|
| We haven't added any publications to our database yet. | |||
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.
Protocols
| relevant to this product |
|---|
| BC134A protocol |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.